Get the latest NAV of LIC MF Healthcare Fund Direct Growth. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.
₹30.36
▲1.2%1D
NAV as on 13 May 2025
19.46%/per year
Since Inception
▲▼
119 people have invested ₹ 2.8L in LIC MF Healthcare Fund Direct Growth in the last three months
Fund returns vs Benchmark returns vs Category Average returns as on (13-May-25)
The fund has outperformed the benchmark (Nifty 500) over 1Y, 3Y, but underperformed over 5Y.
Powered by IND quant engine
IND ranking is not available for this fund.
Calculate SIP and lumpsum returns based on historical performance
Total Investment
0
Profit
Total Corpus
0
See fund asset allocation details as on (15-Apr-25)
Fund Distribution
as on (15-Apr-25)
Equity 95.8%
Debt & Cash 4.2%
See fund sector allocation details as on (15-Apr-25)
Sector Allocation
Equity 95.8%
Debt & Cash 4.2%
Top 2 Sectors in March were Health, Basic Materials
Health
93%
Basic Materials
7%
Health
93%
Basic Materials
7%
as on (30-Apr-25)
Equity
Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.
Expense ratio | 1.22% |
Benchmark | BSE Healthcare TR INR |
AUM | ₹84 Cr |
Inception Date | 28 February, 2019 |
Min Lumpsum/SIP | ₹5000/₹200 |
Exit Load | 1.0% |
Lock In | No Lock-in |
TurnOver | 414.8% |
STCG | Selling mutual fund before 1 year, returns taxed at 20%. |
LTCG | After 1 year, 12.5% tax on returns over ₹1.25 lakh/year. |
Risk | Very High Risk |
LIC MF Healthcare Fund Direct Growth is an equity fund. This fund was started on 28 February, 2019. The fund is managed by Karan Doshi. The fund could potentially beat inflation in the long-run.
LIC MF Healthcare Fund Direct Growth has given a CAGR return of 19.46% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 18.06%, 20.64% and 18.53% respectively.
LIC MF Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Basic Materials. Its top holdings are Sun Pharmaceuticals Industries Ltd, Piramal Pharma Ltd, Torrent Pharmaceuticals Ltd, Cipla Ltd, Aurobindo Pharma Ltd
As it is a sector - healthcare mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 20%For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefitDividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.
The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. However there can be no assurance that the investment objective under the scheme will be realized.
Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 200.00. LIC MF Healthcare Fund Direct Growth has no lock in period.
Fund Manager of LIC MF Healthcare Fund Direct Growth, since 31 July 2023
5Y CAGR
▲ 34.82
5Y CAGR
▲ 28.61
5Y CAGR
▲ 27.09
5Y CAGR
▲ 34.08
5Y CAGR
▲ 25.95
LIC MF Healthcare Fund
VS
Nippon India Pharma Fund Direct Growth
LIC MF Healthcare Fund Direct Growth | Absolute Returns | CAGR Returns |
1 Month Returns | 0.89% | 0.89% |
6 Month Returns | -5.32% | -5.32% |
1 Year Returns | 18.06% | 18.06% |
3 Years Returns | 75.58% | 20.64% |
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
LIC MF Healthcare Fund Direct Growth | -1.08 | -2.1 | -2.49 |
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
LIC MF Healthcare Fund Direct Growth | 0.94 | 0.93 | 0.92 |
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
LIC MF Healthcare Fund Direct Growth | 0.59 | 0.67 | 0.84 |
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
LIC MF Healthcare Fund Direct Growth | 19.76 | 16.53 | 15.86 |